{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:42:45Z","timestamp":1789609365841,"version":"build-2803163510"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Vasculitis is an inflammatory disorder of the blood vessels that causes damage to a wide variety of organs through tissue ischemia. Vasculitis is classified according to the size (large, medium, or small) of the blood vessels. In 2020, VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome, a novel autoinflammatory syndrome, was described. Somatic mutations in methionine-41 of UBA1, the major E1 enzyme that initiates ubiquitylation, are attributed to this disorder. This new disease entity connects seemingly unrelated conditions: inflammatory syndromes (relapsing chondritis, Sweet's syndrome, or neutrophilic dermatosis) and hematologic disorders (myelodysplastic syndrome or multiple myeloma). Notably, such patients sometimes develop vasculitis, such as giant cell arteritis and polyarteritis nodosa, and fulfill the corresponding classification criteria for vasculitis. Thus, vasculitis can be an initial manifestation of VEXAS syndrome. In this research topic exploring the link between autoinflammatory diseases and vasculitis, we first provide an overview of the disease mechanisms and clinical phenotypes of VEXAS syndrome. Then, a literature review using the PubMed database was performed to delineate the clinical characteristics of vasculitis associated with VEXAS syndrome. Finally, the therapeutic options and unmet needs of VEXAS syndrome are discussed.<\/jats:p>","DOI":"10.3389\/fmed.2022.983939","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:01:05Z","timestamp":1660539665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Vasculitis associated with VEXAS syndrome: A literature review"],"prefix":"10.3389","volume":"9","author":[{"given":"Ryu","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Kiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"Bernot","year":"1997","journal-title":"Nat Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.cell.2010.03.002","article-title":"Autoinflammatory disease reloaded: a clinical perspective","volume":"140","author":"Kastner","year":"2010","journal-title":"Cell."},{"key":"B4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaci.2020.09.014","article-title":"The systemic autoinflammatory diseases: coming of age with the human genome","volume":"146","author":"Stone","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaci.2020.08.017","article-title":"Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach","volume":"146","author":"Nigrovic","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41584-020-0377-5","article-title":"Moving towards a systems-based classification of innate immune-mediated diseases","volume":"16","author":"Savic","year":"2020","journal-title":"Nat Rev Rheumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz","year":"2021","journal-title":"Nat Rev Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/25785826.2018.1524105","article-title":"Diagnosis and treatment of autoinflammatory diseases in adults: a clinical approach from rheumatologists","volume":"41","author":"Koga","year":"2018","journal-title":"Immunol Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13497413.2018.1481579","article-title":"Familial Mediterranean fever: overview of pathogenesis, clinical features and management","volume":"41","author":"Migita","year":"2018","journal-title":"Immunol Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.41992","article-title":"VEXAS syndrome: a case series from a single-center cohort of Italian patients with vasculitis","volume":"74","author":"Muratore","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1093\/rheumatology\/keab782","article-title":"VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis","volume":"61","author":"P\u00e0mies","year":"2022","journal-title":"Rheumatology."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.01.042","article-title":"VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist","author":"Sterling","year":"2022","journal-title":"J Am Acad Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Arlet","year":"2021","journal-title":"N Engl J Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","article-title":"VEXAS syndrome in a woman","volume":"60","author":"Barba","year":"2021","journal-title":"Rheumatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3324\/haematol.2021.280238","article-title":"VEXAS syndrome in a female patient with constitutional 45, X (Turner syndrome)","volume":"107","author":"Stubbins","year":"2022","journal-title":"Haematologica."},{"key":"B19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu Rev Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ceb.2013.07.004","article-title":"Dynamic regulation of ubiquitin-dependent cell cycle control","volume":"25","author":"Craney","year":"2013","journal-title":"Curr Opin Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","article-title":"Disorders of ubiquitylation: unchained inflammation","volume":"18","author":"Beck","year":"2022","journal-title":"Nat Rev Rheumatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-100617-062802","article-title":"Principles of ubiquitin-dependent signaling","volume":"34","author":"Oh","year":"2018","journal-title":"Annu Rev Cell Dev Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","article-title":"Ubiquitylation at the crossroads of development and disease","volume":"19","author":"Rape","year":"2018","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-kappaB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cell.2016.03.003","article-title":"Types of ubiquitin ligases","volume":"165","author":"Morreale","year":"2016","journal-title":"Cell."},{"key":"B26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrm2673","article-title":"Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways","volume":"10","author":"Schulman","year":"2009","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br J Haematol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.mayocp.2021.06.006","article-title":"Clinical heterogeneity of the VEXAS syndrome: a case series","volume":"96","author":"Koster","year":"2021","journal-title":"Mayo Clin Proc."},{"key":"B29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","article-title":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients","volume":"186","author":"Georgin-Lavialle","year":"2022","journal-title":"Br J Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS","volume":"149","author":"van der Made","year":"2022","journal-title":"J Allergy Clin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdcr.2021.06.010","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome-clinical presentation of a newly described somatic, autoinflammatory syndrome","volume":"14","author":"Alhomida","year":"2021","journal-title":"JAAD Case Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0140-6736(21)01430-6","article-title":"Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: fevers, myalgia, arthralgia, auricular chondritis, and erythema nodosum","volume":"398","author":"Dehghan","year":"2021","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jamadermatol.2021.3344","article-title":"UBA1 variations in neutrophilic dermatosis skin lesions of patients with VEXAS syndrome","volume":"157","author":"Zakine","year":"2021","journal-title":"JAMA Dermatol."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02340-4.","article-title":"VEXAS syndrome in dermatology","author":"Afsahi","year":"2022","journal-title":"Arch Dermatol Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1111\/jdv.17924","article-title":"The spectrum of skin disease in VEXAS syndrome: a report of a novel clinico-histopathologic presentation","volume":"36","author":"Khosravi-Hafshejani","year":"2022","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40164-022-00262-5","article-title":"Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome","volume":"11","author":"Lacombe","year":"2022","journal-title":"Exp Hematol Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/blood.2021011455","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood."},{"key":"B39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/MOH.0b013e32834da9d2","article-title":"Update on anemia and neutropenia in copper deficiency","volume":"19","author":"Lazarchick","year":"2012","journal-title":"Curr Opin Hematol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01668.x","article-title":"Acute myeloid leukaemia with Pseudo-Chediak-Higashi granules and intracytoplasmic vacuoles","author":"Gajendra","year":"2011","journal-title":"Eur J Haematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4274\/tjh.galenos.2018.2018.0104","article-title":"Vacuolization in myeloid and erythroid precursors in a child with menkes disease","volume":"36","author":"Sayin","year":"2019","journal-title":"Turk J Haematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4274\/tjh.galenos.2018.2018.0230","article-title":"Different presentations of patients with transcobalamin II deficiency: a single-center experience from Turkey","volume":"36","author":"Unal","year":"2019","journal-title":"Turk J Haematol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1053\/j.seminhematol.2021.10.006","article-title":"Thrombotic manifestations of VEXAS syndrome","volume":"58","author":"Groarke","year":"2021","journal-title":"Semin Hematol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11239-021-02608-y","article-title":"Thrombosis in VEXAS syndrome","volume":"53","author":"Oo","year":"2022","journal-title":"J Thromb Thrombolysis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.seminhematol.2021.10.002","article-title":"VEXAS within the spectrum of rheumatologic disease","volume":"58","author":"Koster","year":"2021","journal-title":"Semin Hematol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.21.0370","article-title":"A man in his sixties with chondritis and bone marrow failure","author":"Midtvedt","year":"2022","journal-title":"Tidsskr Nor Laegeforen."},{"key":"B47","doi-asserted-by":"publisher","first-page":"102636","DOI":"10.1016\/j.bcmd.2021.102636","article-title":"A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis","volume":"93","author":"Kao","year":"2022","journal-title":"Blood Cells Mol Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/art.42257.","article-title":"VEXAS syndrome presenting as treatment-refractory polyarteritis nodosa","volume":"371","author":"Itagane","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1182\/bloodadvances.2021004749","article-title":"Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience","volume":"6","author":"Diarra","year":"2022","journal-title":"Blood Adv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1002\/art.41775","article-title":"Extensive multiple organ involvement in VEXAS syndrome","volume":"73","author":"Takahashi","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"800149","DOI":"10.3389\/fimmu.2021.800149","article-title":"Case report: genetic double strike: VEXAS and TET2-positive myelodysplastic syndrome in a patient with long-standing refractory autoinflammatory disease","volume":"12","author":"L\u00f6tscher","year":"2021","journal-title":"Front Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11926-020-00948-x","article-title":"Pathogenesis of giant cell arteritis and takayasu arteritis-similarities and differences","volume":"22","author":"Watanabe","year":"2020","journal-title":"Curr Rheumatol Rep."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030495.","article-title":"Mimickers of large vessel giant cell arteritis","author":"Ramon","year":"2022","journal-title":"J Clin Med."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.08.21266919","article-title":"A high-throughput amplicon screen for somatic UBA1 variants in cytopenic and giant cell arteritis cohorts","author":"Poulter","year":"2022","journal-title":"J Clin Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMc1409206","article-title":"Giant-cell arteritis and polymyalgia rheumatica","volume":"371","author":"Weyand","year":"2014","journal-title":"N Engl J Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"587089","DOI":"10.3389\/fimmu.2020.587089","article-title":"Cellular signaling pathways in medium and large vessel vasculitis","volume":"11","author":"Watanabe","year":"2020","journal-title":"Front Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/art.1780330805","article-title":"The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa","volume":"33","author":"Lightfoot RW","year":"1990","journal-title":"Arthritis Rheum."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B60","doi-asserted-by":"publisher","first-page":"E524","DOI":"10.1503\/cmaj.211770","article-title":"Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome","volume":"194","author":"Stubbins","year":"2022","journal-title":"CMAJ."},{"key":"B61","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11926-007-0049-3","article-title":"Small-vessel vasculitis","volume":"9","author":"Iglesias-Gamarra","year":"2007","journal-title":"Curr Rheumatol Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"619705","DOI":"10.3389\/fimmu.2020.619705","article-title":"Role of Neutrophils in systemic vasculitides","volume":"11","author":"Michailidou","year":"2020","journal-title":"Front Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1136\/annrheumdis-2021-220876","article-title":"Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan","volume":"80","author":"Kirino","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1093\/rheumatology\/keab211","article-title":"VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy","volume":"60","author":"Magnol","year":"2021","journal-title":"Rheumatology."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1093\/rheumatology\/keac054","article-title":"VEXAS syndrome: favourable clinical and partial haematological responses to subcutaneous abatacept therapy with 30-month follow up","volume":"61","author":"Pathmanathan","year":"2022","journal-title":"Rheumatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminhematol.2021.09.001","article-title":"Toward a pathophysiology inspired treatment of VEXAS syndrome","volume":"58","author":"Heiblig","year":"2021","journal-title":"Semin Hematol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"895965","DOI":"10.3389\/fmed.2022.895965","article-title":"Trisomy 8 Associated Clonal Cytopenia Featured With Acquired Auto-Inflammation and Its Response to JAK Inhibitors","volume":"9","author":"Fu","year":"2022","journal-title":"Front Med."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016642","article-title":"Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multi-center study","author":"Heiblig","year":"2022","journal-title":"Blood."},{"key":"B70","doi-asserted-by":"publisher","first-page":"881705","DOI":"10.3389\/fimmu.2022.881705","article-title":"Perspectives of JAK Inhibitors for large vessel vasculitis","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1200\/JCO.2002.04.117","article-title":"Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B","volume":"20","author":"Silverman","year":"2002","journal-title":"J Clin Oncol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1093\/rheumatology\/keab866","article-title":"Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis","volume":"61","author":"Cordts","year":"2022","journal-title":"Rheumatology."},{"key":"B73","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bjh.17893","article-title":"Azacitidine for patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry","volume":"196","author":"Comont","year":"2022","journal-title":"Br J Haematol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41409-021-01544-y","article-title":"Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report","volume":"57","author":"Loschi","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"B75","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41586-019-1879-7","article-title":"A brief history of human disease genetics","volume":"577","author":"Claussnitzer","year":"2020","journal-title":"Nature."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/cimb44030074","article-title":"Use of next-generation sequencing for identifying mitochondrial disorders","volume":"44","author":"Mahmud","year":"2022","journal-title":"Curr Issues Mol Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1056\/NEJMe2030754","article-title":"Hiding in plain sight - somatic mutation in human disease","volume":"383","author":"Levy-Lahad","year":"2020","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.983939\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:01:07Z","timestamp":1660539667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.983939\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":77,"alternative-id":["10.3389\/fmed.2022.983939"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.983939","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"article-number":"983939"}}